FTH-002 / Faeth Therapeutics - LARVOL DELTA

Faeth Therapeutics to Present at Raymond James Biotech Private Company Showcase (Businesswire) - "Faeth Therapeutics...will present today at the Raymond James Biotech Private Company Showcase. Oliver and Debbie will discuss Faeth’s lead PIKTOR program development plans...Faeth's lead program, FTH-001/003 or 'PIKTOR,' features the combination of serabelisib, a PI3Kɑ inhibitor, and sapanisertib, an mTORC 1/2 inhibitor....Additionally, Faeth's second clinical initiative involves FTH-002, a specially designed amino acid sachet administered alongside an amino acid-restricted diet and radio/chemotherapy."

Clinical • Breast Cancer • Endometrial Cancer • Gynecologic Cancers • Oncology • Ovarian Cancer • Solid Tumor